CRCM LP
Long book
$141.2M
Q1 2026
Positions
8
Top-10 weight
100%
concentration
Last quarter
-15.5%
SPY +14.8%
Turnover
42%
of book per quarter
Strategy in plain words
auto-generated from filingsCRCM LP is a wealth-management firm allocating client money, specialised in financials (90% of the long book), running a $141.2M US long book across 8 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. The portfolio is actively managed, with meaningful quarterly turnover. Current anchor positions: ISHARES GOLD TRUST, AI FINANCIAL CORP, PLAYBOY INC, BURNING ROCK BIOTECH LTD-ADR, STAAR SURGICAL CO.
Over the last 9 quarters its long book ran on average 4.8pp per quarter ahead of the S&P 500, beating the index in 6 of 9 quarters. Its holdings are mechanical (indexing / client flows), so position changes carry no stock-picking signal.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
-10.3%
Q2 2024
+6.0%
Q3 2024
+43.7%
Q4 2024
+0.5%
Q1 2025
+57.5%
Q2 2025
+14.4%
Q3 2025
+4.3%
Q4 2025
-17.1%
Q1 2026
-15.5%
Sector allocation
Financials 62%
Consumer discretionary 26%
Healthcare 12%
Long book by quarter
What does CRCM LP own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| AIFC AI FINANCIAL CORP | Financials | 12.6M | $14.0M | 9.9% | +15.3% |
| PLBY PLAYBOY INC | Consumer discretionary | 4.3M | $6.6M | 4.7% | +17.8% |
| STAA STAAR SURGICAL CO | Healthcare | 100.0K | $1.9M | 1.3% | New |
| PCAP PROCAP ACQUISITION CORP - A | Financials | 152.4K | $1.6M | 1.1% | -50.3% |
| PCSC PERCEPTIVE CAPITAL SOLUTIONS | Healthcare | 116.2K | $1.3M | 0.9% | -72.3% |
| USBC USBC INC | Financials | 555.3K | $214K | 0.2% | -78.4% |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 13, 2026 | 16 | $141.2M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 13, 2026 | 30 | $296.0M | canonical | SEC ↗ |
| Q3 2025 | 13F-HR/ARESTATEMENT | Nov 14, 2025 | 48 | $345.7M | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 12, 2025 | 48 | $345.7M | SEC ↗ | |
| Q2 2025 | 13F-HR | Aug 13, 2025 | 37 | $336.6M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 14, 2025 | 23 | $245.3M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 7, 2025 | 20 | $245.9M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 13, 2024 | 13 | $154.5M | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 13, 2024 | 16 | $138.3M | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 15, 2024 | 14 | $132.9M | canonical | SEC ↗ |